Literature DB >> 23540659

Endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis: testing the current guidelines.

Moises Ilan Nevah Rubin1, Nirav C Thosani, Rajasekhar Tanikella, David S Wolf, Michael B Fallon, Frank J Lukens.   

Abstract

BACKGROUND: Current guidelines include an algorithm for predicting choledocholithiasis. Presence of any very strong predictor or both strong predictors confers a high (>50%) probability of choledocholithiasis. Absence of predictors confers low risk (<10%) of choledocholithiasis. Other combinations have an intermediate risk of choledocholithiasis. AIM: Determine accuracy of the proposed algorithm in predicting choledocholithiasis.
METHODS: Retrospective analysis of all endoscopic retrograde cholangiopancreatographies performed for suspected choledocholithiasis in 3 years in a Tertiary care hospital and a community hospital serviced by The University of Texas Health Science Center at Houston Division of Gastroenterology. Application of the guidelines, and comparing results to endoscopic retrograde cholangiopancreatography findings.
RESULTS: A total of 1080 endoscopic retrograde cholangiopancreatographies were performed; 521 for choledocholithiasis. Most patients were Hispanic and female. Univariate analysis: presence of any very strong predictor and both strong predictors had an OR for choledocholithiasis of 3.30 and 2.36 respectively. Multivariate analysis: odds of choledocholithiasis with any very strong predictor was 2.87, and both strong predictors 3.24. Choledocholithiasis was present in 71.5%, and 41% of patients with high, and intermediate risk respectively.
CONCLUSION: This study confirms the utility of clinical predictors for the diagnosis of choledocholithiasis. All of the very strong predictors and one of the strong predictors increased the odds of choledocholithiasis. Patients with high risk for choledocholithiasis had a probability of 79% of choledocholithiasis. Sensitivity and specificity of current predictors are too low to obviate the possible need of non-invasive tests to confirm or exclude choledocholithiasis in all risk groups.
Copyright © 2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Choledocholithiasis; Clinical predictors; Endoscopic retrograde cholangiopancreatography

Mesh:

Substances:

Year:  2013        PMID: 23540659     DOI: 10.1016/j.dld.2013.02.005

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  18 in total

1.  Endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis: From guidelines to clinical practice.

Authors:  Joana Magalhães; Bruno Rosa; José Cotter
Journal:  World J Gastrointest Endosc       Date:  2015-02-16

2.  Dynamic liver test patterns do not predict bile duct stones.

Authors:  Chung Yao Yu; Nitzan Roth; Niraj Jani; Jaehoon Cho; Jacques Van Dam; Rick Selby; James Buxbaum
Journal:  Surg Endosc       Date:  2019-03-25       Impact factor: 4.584

3.  An assessment of existing risk stratification guidelines for the evaluation of patients with suspected choledocholithiasis.

Authors:  Alejandro L Suarez; Nicolas T LaBarre; Peter B Cotton; K Mark Payne; Gregory A Coté; B Joseph Elmunzer
Journal:  Surg Endosc       Date:  2016-02-19       Impact factor: 4.584

4.  Predicting the likelihood of a persistent bile duct stone in patients with suspected choledocholithiasis: accuracy of existing guidelines and the impact of laboratory trends.

Authors:  Megan A Adams; Amy E Hosmer; Erik J Wamsteker; Michelle A Anderson; Grace H Elta; Nisa M Kubiliun; Richard S Kwon; Cyrus R Piraka; James M Scheiman; Akbar K Waljee; Hero K Hussain; B Joseph Elmunzer
Journal:  Gastrointest Endosc       Date:  2015-03-16       Impact factor: 9.427

Review 5.  Systematic review and meta-analysis of the 2010 ASGE non-invasive predictors of choledocholithiasis and comparison to the 2019 ASGE predictors.

Authors:  Louie Wang; Sarah Mirzaie; Tavit Dunnsiri; Formosa Chen; Holly Wilhalme; Ian T MacQueen; Henry Cryer; Anaar Eastoak-Siletz; Michelle Guan; Callie Cuff; James H Tabibian
Journal:  Clin J Gastroenterol       Date:  2022-01-24

6.  Suspected common bile duct stones: reduction of unnecessary ERCP by pre-procedural imaging and timing of ERCP.

Authors:  Christina J Sperna Weiland; Evelien C Verschoor; Alexander C Poen; Xavier J M N Smeets; Niels G Venneman; Abha Bhalla; Ben J M Witteman; Hester C Timmerhuis; Devica S Umans; Jeanin E van Hooft; Marco J Bruno; P Fockens; Robert C Verdonk; Joost P H Drenth; Erwin J M van Geenen
Journal:  Surg Endosc       Date:  2022-09-26       Impact factor: 3.453

7.  Evaluation of the American Society of Gastrointestinal Endoscopy 2019 and the European Society of Gastrointestinal Endoscopy guidelines' performances for choledocholithiasis prediction in clinically suspected patients: A retrospective cohort study.

Authors:  Suppadech Tunruttanakul; Borirak Chareonsil; Kotchakorn Verasmith; Jayanton Patumanond; Chatchai Mingmalairak
Journal:  JGH Open       Date:  2022-05-25

8.  Development of a risk score for choledocholithiasis in pediatric patients.

Authors:  Mauro Ariel Capparelli; Pablo Damian D Alessandro; Horacio Alberto Questa; Victor Hugo Ayarzabal; Maria Marcela Bailez; Marcelo Eugenio Barrenechea
Journal:  Pediatr Surg Int       Date:  2021-06-19       Impact factor: 1.827

9.  Performance of the Choledocholithiasis Diagnostic Score in Patients with Acute Cholecystitis.

Authors:  Catarina Gouveia; Rui Loureiro; Rosa Ferreira; Alexandre Oliveira Ferreira; António Alberto Santos; Maria Pia Costa Santos; Carolina Palmela; Marília Cravo
Journal:  GE Port J Gastroenterol       Date:  2017-09-15

10.  Risk assessment of choledocholithiasis prior to laparoscopic cholecystectomy and its management options.

Authors:  Ausra Aleknaite; Gintaras Simutis; Juozas Stanaitis; Jonas Valantinas; Kestutis Strupas
Journal:  United European Gastroenterol J       Date:  2017-09-06       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.